Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


2 Ann Hematol
1 Biochem Biophys Res Commun
5 Blood
1 BMC Cancer
5 Bone Marrow Transplant
1 Br J Cancer
2 Br J Haematol
1 Cancer
1 Int J Hematol
2 Leuk Lymphoma
1 Leukemia
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Hematol

  1. ALVAREZ-LARRAN A, Lopez-Guerra M, Rozman M, Correa JG, et al
    Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.
    Ann Hematol. 2019;98:2319-2328.
    PubMed     Text format     Abstract available

  2. CRUGNOLA M, Castagnetti F, Breccia M, Ferrero D, et al
    Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
    Ann Hematol. 2019;98:2329-2338.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  3. WANG K, Wang C, Zhu CJ, Li G, et al
    Corrigendum to "4-Amino-2-Trifluoromethyl-Phenyl Retinate induced leukemia cell differentiation by decreasing eIF6" [Biochem. Biophys. Res. Commun. 503(3) (2018) 2033-2039].
    Biochem Biophys Res Commun. 2019 Sep 16. pii: S0006-291X(19)31343.
    PubMed     Text format    


  4. ASSLABER D, Qi Y, Maeding N, Steiner M, et al
    B-cell specific IRF4 deletion accelerates Chronic Lymphocytic Leukemia development by enhanced tumor immune evasion.
    Blood. 2019 Sep 19. pii: blood.2019000973. doi: 10.1182/blood.2019000973.
    PubMed     Text format     Abstract available

  5. KHATRI SS, Kim AS
    Li-Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma.
    Blood. 2019;134:993.
    PubMed     Text format    

    Highs and lows of minimal residual disease in CLL.
    Blood. 2019;133:386-388.
    PubMed     Text format    

  7. GONZALEZ-GARCIA S, Mosquera M, Fuentes P, Palumbo T, et al
    IL-7R is essential for leukemia-initiating cell activity and pathogenesis of T-cell acute lymphoblastic leukemia.
    Blood. 2019 Sep 17. pii: blood.2019000982. doi: 10.1182/blood.2019000982.
    PubMed     Text format     Abstract available

  8. CHAPIRO E, Pramil E, Diop M, Roos-Weil D, et al
    Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
    Blood. 2019 Sep 16. pii: blood.2019001187. doi: 10.1182/blood.2019001187.
    PubMed     Text format     Abstract available

    BMC Cancer

  9. ZHOU J, Zhou LY, Tang X, Zhang J, et al
    Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients.
    BMC Cancer. 2019;19:930.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  10. SOLOMON SR, Solh M, Jackson KC, Zhang X, et al
    Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0675.
    PubMed     Text format     Abstract available

  11. GATWOOD KS, Labopin M, Savani BN, Finke J, et al
    Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0673.
    PubMed     Text format     Abstract available

  12. MA Y, Qu C, Dai H, Yin J, et al
    Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0677.
    PubMed     Text format    

  13. TOMORI S, Morishima S, Nishi Y, Nakachi S, et al
    Transplant-related complications are impediments to the success of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia patients in non-complete remission.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0669.
    PubMed     Text format     Abstract available

  14. TACHIBANA T, Ishizaki T, Takahashi S, Najima Y, et al
    Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.
    Bone Marrow Transplant. 2019 Sep 19. pii: 10.1038/s41409-019-0689.
    PubMed     Text format    

    Br J Cancer

  15. TOKAREW N, Ogonek J, Endres S, von Bergwelt-Baildon M, et al
    Teaching an old dog new tricks: next-generation CAR T cells.
    Br J Cancer. 2019;120:26-37.
    PubMed     Text format     Abstract available

    Br J Haematol

  16. KHAKWANI M, Srinath S, Pratt G, Moss P, et al
    A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia.
    Br J Haematol. 2019;184:7.
    PubMed     Text format    

  17. HU AY, Zhou T
    Sequential B-lymphoid and myeloid blastic transformation of Philadelphia chromosome-negative myeloproliferative neoplasm.
    Br J Haematol. 2019;184:8.
    PubMed     Text format    


  18. BLOOMHARDT HM, Sint K, Ross WL, Rotatori J, et al
    Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
    Cancer. 2019 Sep 19. doi: 10.1002/cncr.32512.
    PubMed     Text format     Abstract available

    Int J Hematol

  19. NAGAFUJI K, Matsumura I, Shimose T, Kawaguchi T, et al
    Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).
    Int J Hematol. 2019 Sep 19. pii: 10.1007/s12185-019-02736.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  20. XU H, Liu J, Shen N, Zhao Z, et al
    The interaction of tumor cells and myeloid-derived suppressor cells in chronic myelogenous leukemia.
    Leuk Lymphoma. 2019 Sep 18:1-10. doi: 10.1080/10428194.2019.1658098.
    PubMed     Text format     Abstract available

  21. SEA JL, Orgel E, Chen T, Paszkiewicz RL, et al
    Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Sep 16:1-9. doi: 10.1080/10428194.2019.1666379.
    PubMed     Text format     Abstract available


  22. THASTRUP M, Marquart HV, Levinsen M, Grell K, et al
    Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
    Leukemia. 2019 Sep 18. pii: 10.1038/s41375-019-0570.
    PubMed     Text format     Abstract available

    PLoS One

  23. CHAHAL KK, Li J, Kufareva I, Parle M, et al
    Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
    PLoS One. 2019;14:e0214901.
    PubMed     Text format     Abstract available

  24. TANASKOVIC O, Verga Falzacappa MV, Pelicci PG
    Human cord blood (hCB)-CD34+ humanized mice fail to reject human acute myeloid leukemia cells.
    PLoS One. 2019;14:e0217345.
    PubMed     Text format     Abstract available

  25. OOSTEROM N, de Jonge R, Smith DEC, Pieters R, et al
    Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
    PLoS One. 2019;14:e0221591.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.